Hyperimmune immunoglobulin for people with COVID-19

Catherine Kimber; Sarah J. Valk; Khai Li Chai; Vanessa Piechotta; Claire Iannizzi; Ina Monsef; Erica M. Wood; Abigail A. Lamikanra; David J. Roberts; Zoe McQuilten; Cynthia So-Osman; Lise J. Estcourt; Nicole Skoetz

doi:10.1002/14651858.CD015167

Hyperimmune immunoglobulin for people with COVID-19

Catherine Kimber, Sarah J. Valk, Khai Li Chai, Vanessa Piechotta, Claire Iannizzi, Ina Monsef, Erica M. Wood, Abigail A. Lamikanra, David J. Roberts, Zoe McQuilten, Cynthia So-Osman, Lise J. Estcourt, Nicole Skoetz^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence.

Original language	English
Article number	CD015167
Journal	The Cochrane database of systematic reviews
Volume	2021
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD015167
Publication status	Published - 12 Oct 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Access to Document

10.1002/14651858.CD015167

Cite this

@article{de8cd640eaf349279bb27fbcda30b936,

title = "Hyperimmune immunoglobulin for people with COVID-19",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence.",

author = "Catherine Kimber and Valk, {Sarah J.} and Chai, {Khai Li} and Vanessa Piechotta and Claire Iannizzi and Ina Monsef and Wood, {Erica M.} and Lamikanra, {Abigail A.} and Roberts, {David J.} and Zoe McQuilten and Cynthia So-Osman and Estcourt, {Lise J.} and Nicole Skoetz",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = oct,

day = "12",

doi = "10.1002/14651858.CD015167",

language = "English",

volume = "2021",

journal = "The Cochrane database of systematic reviews",

issn = "1465-1858",

publisher = "Cochrane Collaboration",

number = "10",

}

TY - JOUR

T1 - Hyperimmune immunoglobulin for people with COVID-19

AU - Kimber, Catherine

AU - Valk, Sarah J.

AU - Chai, Khai Li

AU - Piechotta, Vanessa

AU - Iannizzi, Claire

AU - Monsef, Ina

AU - Wood, Erica M.

AU - Lamikanra, Abigail A.

AU - Roberts, David J.

AU - McQuilten, Zoe

AU - So-Osman, Cynthia

AU - Estcourt, Lise J.

AU - Skoetz, Nicole

PY - 2021/10/12

Y1 - 2021/10/12

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence.

UR - http://www.scopus.com/inward/record.url?scp=85117068546&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD015167

DO - 10.1002/14651858.CD015167

M3 - Article

AN - SCOPUS:85117068546

SN - 1465-1858

VL - 2021

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

IS - 10

M1 - CD015167

ER -

Hyperimmune immunoglobulin for people with COVID-19

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this